Evidence map›Paper›PMID 40770905›Full record

ArticleBritish journal of haematology2025

Blood donor populations reveal a clear association between ferritin and change in haemoglobin levels.

Amber Meulenbeld, Esa V Turkulainen, Wanjin Li, Mart R Pothast, Hongchao Qi, Elias Allara, Emanuele Di Angelantonio, INTERVAL Trial Group, Ronél Swanevelder, Tinus Brits and 7 more

Abstract read
In one paragraph

Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Amber MeulenbeldDonor Health, Department of Research, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-9571-2179
Esa V TurkulainenResearch and Development, Finnish Red Cross Blood Service, Helsinki, Finland.
Wanjin LiSchool of Population and Global Health, McGill University, Montreal, Canada.
Mart R PothastTransfusion Technology Assessment, Department of Research, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.
Hongchao QiBHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Elias AllaraBHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Emanuele Di AngelantonioBHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
INTERVAL Trial Group
Ronél SwanevelderBusiness Intelligence, South African National Blood Service, Johannesburg, South Africa.
Tinus BritsBusiness Intelligence, South African National Blood Service, Johannesburg, South Africa.
Yared PaalvastMedical Donor Affairs, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-1648-9851
Katja van den HurkDonor Health, Department of Research, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.
Hanke L MatlungMolecular Hematology, Department of Research, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.
Dorine W SwinkelsCenter for Iron Disorders, Sanquin Blood Supply Foundation, Amsterdam, Noord-Holland, The Netherlands.ORCID https://orcid.org/0000-0002-1040-9446
W Alton RussellSchool of Population and Global Health, McGill University, Montreal, Canada.
Mikko ArvasResearch and Development, Finnish Red Cross Blood Service, Helsinki, Finland.
Mart P JanssenTransfusion Technology Assessment, Department of Research, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.

Funding

AABB FoundationSanquin Blood Supply Foundation PPOC21-10/L2590Sanquin Blood Supply Foundation PPOC23-09/L2753
6 · The paper itself

Abstract

Many blood establishments worldwide monitor serum ferritin alongside mandatory haemoglobin (Hb) screening to better protect donors from iron deficiency and anaemia. However, the relationship between ferritin and Hb, and the ferritin level that indicates iron deficiency, remains unclear. Whole blood donation results in significant iron loss, and repeated donations can deplete iron stores. This study analysed over 1 million whole-blood donations from four countries to explore the association between Hb change and ferritin levels. Hb change was defined relative to a donor's initial Hb level. A consistent two-phase relationship emerged: At low ferritin levels, Hb change is linearly associated with log ferritin; above a certain threshold, this association disappears as donors recover their reference Hb. The transition point and slope of this association differ by population. These results suggest that ferritin thresholds for identifying limited Hb recovery are not universal but population-specific, influenced by biological and procedural differences, including ferritin assay variability. While the overall pattern is consistent, the absence of standardized procedures and assays limits the ability to define global ferritin thresholds for donor care. This underscores the importance of localized approaches to ferritin-based donor management and the need for harmonized methodologies across blood services.

Indexed as

Blood DonorsFerritinsHemoglobinsAdultFemaleHumansMaleMiddle AgedFerritinsHemoglobinsblood donorsferritin–haemoglobin associationferritin thresholdiron deficiency

Identifiers

PMID40770905
PMCPMC12436240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.